The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

The Indian Council of Medical Research is spearheading the development of a human vaccine against avian influenza H5N1, a significant threat to animal and human health. Their efforts aim to control ...

We recently compiled a list of the 10 Firms Fall Amid Disappointing Earnings Performance. In this article, we are going to take a look at where Moderna Inc.

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Moderna's stock roared higher on the back of news about potential AI mRNA vaccines. The company also secured a supply contract in Europe. Shares of Moderna are down 90%, and the company has a huge ...

Oracle chairman Larry Ellison has announced that AI will soon develop customised mRNA vaccine against cancer for every individual within 48 hours.

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...